These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24683532)

  • 21. Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth.
    Chung GE; Yoon JH; Lee JH; Kim HY; Myung SJ; Yu SJ; Lee SH; Lee SM; Kim YJ; Lee HS
    Oncol Rep; 2011 Jun; 25(6):1739-46. PubMed ID: 21455586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DLC1 interacts with 14-3-3 proteins to inhibit RhoGAP activity and block nucleocytoplasmic shuttling.
    Scholz RP; Regner J; Theil A; Erlmann P; Holeiter G; Jähne R; Schmid S; Hausser A; Olayioye MA
    J Cell Sci; 2009 Jan; 122(Pt 1):92-102. PubMed ID: 19066281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1.
    Tripathi BK; Grant T; Qian X; Zhou M; Mertins P; Wang D; Papageorge AG; Tarasov SG; Hunter KW; Carr SA; Lowy DR
    J Cell Biol; 2017 Dec; 216(12):4255-4270. PubMed ID: 29114068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer-Associated Point Mutations in the
    Wang D; Qian X; Sanchez-Solana B; Tripathi BK; Durkin ME; Lowy DR
    Cancer Res; 2020 Sep; 80(17):3568-3579. PubMed ID: 32606003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression.
    Yam JW; Ko FC; Chan CY; Jin DY; Ng IO
    Cancer Res; 2006 Sep; 66(17):8367-72. PubMed ID: 16951145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epithelial junctions and Rho family GTPases: the zonular signalosome.
    Citi S; Guerrera D; Spadaro D; Shah J
    Small GTPases; 2014; 5(4):1-15. PubMed ID: 25483301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor activates the Rho GTPase-activating protein (GAP) Deleted in Liver Cancer 1 via focal adhesion kinase and protein phosphatase 2A.
    Ravi A; Kaushik S; Ravichandran A; Pan CQ; Low BC
    J Biol Chem; 2015 Feb; 290(7):4149-62. PubMed ID: 25525271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flavone inhibits migration through DLC1/RhoA pathway by decreasing ROS generation in breast cancer cells.
    Zhu W; Ma L; Yang B; Zheng Z; Chai R; Liu T; Liu Z; Song T; Li F; Li G
    In Vitro Cell Dev Biol Anim; 2016 May; 52(5):589-97. PubMed ID: 26935193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines.
    Ullmannova V; Popescu NC
    Cancer Detect Prev; 2007; 31(2):110-8. PubMed ID: 17418982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells.
    Du X; Qian X; Papageorge A; Schetter AJ; Vass WC; Liu X; Braverman R; Robles AI; Lowy DR
    Cancer Res; 2012 Sep; 72(17):4405-16. PubMed ID: 22693251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
    Shukla S; Gupta S
    Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer.
    Song LJ; Liu Q; Meng XR; Li ShL; Wang LX; Fan QX; Xuan XY
    Diagn Pathol; 2016 Feb; 11():19. PubMed ID: 26846339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers.
    Wang D; Qian X; Rajaram M; Durkin ME; Lowy DR
    Oncotarget; 2016 Jul; 7(29):45144-45157. PubMed ID: 27174913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity.
    Basak P; Dillon R; Leslie H; Raouf A; Mowat MR
    BMC Cancer; 2015 Sep; 15():630. PubMed ID: 26353792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells.
    Zhou X; Yang XY; Popescu NC
    Biochem Biophys Res Commun; 2012 Apr; 420(2):325-30. PubMed ID: 22425986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Akt phosphorylation of deleted in liver cancer 1 abrogates its suppression of liver cancer tumorigenesis and metastasis.
    Ko FC; Chan LK; Tung EK; Lowe SW; Ng IO; Yam JW
    Gastroenterology; 2010 Oct; 139(4):1397-407. PubMed ID: 20600027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DLC1 negatively regulates angiogenesis in a paracrine fashion.
    Shih YP; Liao YC; Lin Y; Lo SH
    Cancer Res; 2010 Nov; 70(21):8270-5. PubMed ID: 20861185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional cross-talk between ras and rho pathways: a Ras-specific GTPase-activating protein (p120RasGAP) competitively inhibits the RhoGAP activity of deleted in liver cancer (DLC) tumor suppressor by masking the catalytic arginine finger.
    Jaiswal M; Dvorsky R; Amin E; Risse SL; Fansa EK; Zhang SC; Taha MS; Gauhar AR; Nakhaei-Rad S; Kordes C; Koessmeier KT; Cirstea IC; Olayioye MA; Häussinger D; Ahmadian MR
    J Biol Chem; 2014 Mar; 289(10):6839-6849. PubMed ID: 24443565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma.
    Ching YP; Wong CM; Chan SF; Leung TH; Ng DC; Jin DY; Ng IO
    J Biol Chem; 2003 Mar; 278(12):10824-30. PubMed ID: 12531887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers.
    Au SL; Wong CC; Lee JM; Wong CM; Ng IO
    PLoS One; 2013; 8(6):e68226. PubMed ID: 23826380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.